FDA Accepts New Drug Application for INSYS Therapeutics' Naloxo...

07/03/19

FDA Accepts New Drug Application for INSYS Therapeutics' Naloxone Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose  Nasdaq

PHOENIX, July 03, 2019-- INSYS Therapeutics, Inc., announced today that its New Drug Application to the U.S. Food and Drug Administration for its.

[more]